Clinical case series describes a contraindication for SerenoCem Granules™ in mastoid obliteration: Our experience in sixty‐four patients

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles